1948 related articles for article (PubMed ID: 8103531)
1. Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki-67 monoclonal antibodies in melanocytic skin lesions. A quantitative immunohistochemical study.
Rieger E; Hofmann-Wellenhof R; Soyer HP; Kofler R; Cerroni L; Smolle J; Kerl H
J Cutan Pathol; 1993 Jun; 20(3):229-36. PubMed ID: 8103531
[TBL] [Abstract][Full Text] [Related]
2. Proliferative activity in Spitz's naevi compared with other melanocytic skin lesions.
Hofmann-Wellenhof R; Rieger E; Smolle J; Kerl H
Melanoma Res; 1993 Oct; 3(5):313-7. PubMed ID: 7904841
[TBL] [Abstract][Full Text] [Related]
3. Proliferation antigens in cutaneous melanocytic tumors--an immunohistochemical study comparing the transferrin receptor and the Ki 67 antigen.
Soyer HP; Smolle J; Smolle-Juettner FM; Kerl H
Dermatologica; 1989; 179(1):3-9. PubMed ID: 2569990
[TBL] [Abstract][Full Text] [Related]
4. Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody.
Takahashi H; Strutton GM; Parsons PG
Histopathology; 1991 Mar; 18(3):221-7. PubMed ID: 1675189
[TBL] [Abstract][Full Text] [Related]
5. Ki 67 immunostaining in melanocytic skin tumors. Correlation with histologic parameters.
Soyer HP
J Cutan Pathol; 1991 Aug; 18(4):264-72. PubMed ID: 1719049
[TBL] [Abstract][Full Text] [Related]
6. Proliferative activity of cutaneous melanocytic neoplasms defined by a proliferating cell nuclear antigen labelling index.
Tokuda Y; Mukai K; Matsuno Y; Furuya S; Shimosato Y; Takasaki Y; Saida T; Ishihara K
Arch Dermatol Res; 1992; 284(6):319-23. PubMed ID: 1363460
[TBL] [Abstract][Full Text] [Related]
7. Proliferative activity of primary cutaneous melanocytic tumours.
Kuwata T; Kitagawa M; Kasuga T
Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):359-64. PubMed ID: 7906909
[TBL] [Abstract][Full Text] [Related]
8. Proliferative activity assessed by anti-PCNA and Ki67 monoclonal antibodies in canine testicular tumours.
Sarli G; Benazzi C; Preziosi R; Marcato PS
J Comp Pathol; 1994 May; 110(4):357-68. PubMed ID: 7914524
[TBL] [Abstract][Full Text] [Related]
9. Nuclear morphometry, immunohistochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin.
Talve LA; Collan YU; Ekfors TO
J Cutan Pathol; 1996 Aug; 23(4):335-43. PubMed ID: 8864921
[TBL] [Abstract][Full Text] [Related]
10. Growth dynamics of acquired melanocytic nevi. Higher reactivity of proliferating cell nuclear antigen in junctional and compound nevi than intradermal nevi.
Tokuda Y; Saida T; Mukai K; Takasaki Y
J Am Acad Dermatol; 1994 Aug; 31(2 Pt 1):220-4. PubMed ID: 7913717
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
12. Ki-67 immunostaining and stereologic estimation of nuclear volume in melanocytic skin tumors.
Ozer E; Sağol O; Kuyucuoğlu F
Anal Quant Cytol Histol; 1999 Feb; 21(1):42-6. PubMed ID: 10068774
[TBL] [Abstract][Full Text] [Related]
13. Nuclear size and shape parameters correlate with proliferative activity in cutaneous melanocytic tumors.
Smolle J; Hofmann-Wellenhof R; Soyer HP; Stettner H; Kerl H
J Invest Dermatol; 1989 Jul; 93(1):178-82. PubMed ID: 2746003
[TBL] [Abstract][Full Text] [Related]
14. Proliferative activities in Spitz nevus compared with melanocytic nevus and malignant melanoma using expression of PCNA/cyclin and mitotic rate.
Tu P; Miyauchi S; Miki Y
Am J Dermatopathol; 1993 Aug; 15(4):311-4. PubMed ID: 8105711
[TBL] [Abstract][Full Text] [Related]
15. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs.
Roels S; Tilmant K; Ducatelle R
J Comp Pathol; 1999 Jul; 121(1):13-24. PubMed ID: 10373290
[TBL] [Abstract][Full Text] [Related]
16. Malignant melanoma with paradoxical maturation.
Ruhoy SM; Prieto VG; Eliason SL; Grichnik JM; Burchette JL; Shea CR
Am J Surg Pathol; 2000 Dec; 24(12):1600-14. PubMed ID: 11117780
[TBL] [Abstract][Full Text] [Related]
17. Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/Cyclin monoclonal antibodies. Factors affecting reactivity.
Gelb AB; Kamel OW; LeBrun DP; Warnke RA
Am J Pathol; 1992 Dec; 141(6):1453-8. PubMed ID: 1281622
[TBL] [Abstract][Full Text] [Related]
18. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
19. The significance of Ki-67 proliferative index and cyclin D1 expression of dysplastic nevi in the biologic spectrum of melanocytic lesions.
Lebe B; Pabuççuoğlu U; Ozer E
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):160-4. PubMed ID: 17525627
[TBL] [Abstract][Full Text] [Related]
20. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling.
Kamel OW; LeBrun DP; Davis RE; Berry GJ; Warnke RA
Am J Pathol; 1991 Jun; 138(6):1471-7. PubMed ID: 1675840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
